SCYNEXIS Statistics
Total Valuation
SCYNEXIS has a market cap or net worth of $53.63 million. The enterprise value is $1.49 million.
| Market Cap | 53.63M |
| Enterprise Value | 1.49M |
Important Dates
The last earnings date was Monday, August 10, 2026, after market close.
| Earnings Date | Aug 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SCYNEXIS has 9.95 million shares outstanding. The number of shares has increased by 25.40% in one year.
| Current Share Class | 9.95M |
| Shares Outstanding | 9.95M |
| Shares Change (YoY) | +25.40% |
| Shares Change (QoQ) | +85.63% |
| Owned by Insiders (%) | 1.91% |
| Owned by Institutions (%) | 33.62% |
| Float | 7.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.86 |
| Forward PS | 16.27 |
| PB Ratio | 0.82 |
| P/TBV Ratio | 0.82 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.65, with a Debt / Equity ratio of 0.03.
| Current Ratio | 9.65 |
| Quick Ratio | 9.28 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -18.38% and return on invested capital (ROIC) is -136.41%.
| Return on Equity (ROE) | -18.38% |
| Return on Assets (ROA) | -20.82% |
| Return on Invested Capital (ROIC) | -136.41% |
| Return on Capital Employed (ROCE) | -32.68% |
| Weighted Average Cost of Capital (WACC) | 9.94% |
| Revenue Per Employee | $1.07M |
| Profits Per Employee | -$568,611 |
| Employee Count | 18 |
| Asset Turnover | 0.28 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.32% in the last 52 weeks. The beta is 1.10, so SCYNEXIS's price volatility has been similar to the market average.
| Beta (5Y) | 1.10 |
| 52-Week Price Change | -19.32% |
| 50-Day Moving Average | 4.58 |
| 200-Day Moving Average | 5.69 |
| Relative Strength Index (RSI) | 58.68 |
| Average Volume (20 Days) | 114,389 |
Short Selling Information
The latest short interest is 340,795, so 3.43% of the outstanding shares have been sold short.
| Short Interest | 340,795 |
| Short Previous Month | 347,559 |
| Short % of Shares Out | 3.43% |
| Short % of Float | 4.63% |
| Short Ratio (days to cover) | 1.56 |
Income Statement
In the last 12 months, SCYNEXIS had revenue of $19.22 million and -$10.24 million in losses. Loss per share was -$1.33.
| Revenue | 19.22M |
| Gross Profit | 19.22M |
| Operating Income | -22.60M |
| Pretax Income | -10.24M |
| Net Income | -10.24M |
| EBITDA | n/a |
| EBIT | -22.60M |
| Loss Per Share | -$1.33 |
Balance Sheet
The company has $54.08 million in cash and $1.95 million in debt, with a net cash position of $52.14 million or $5.24 per share.
| Cash & Cash Equivalents | 54.08M |
| Total Debt | 1.95M |
| Net Cash | 52.14M |
| Net Cash Per Share | $5.24 |
| Equity (Book Value) | 66.93M |
| Book Value Per Share | 6.73 |
| Working Capital | 50.41M |
Cash Flow
| Operating Cash Flow | -13.31M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -13.31M |
| FCF Per Share | -$1.34 |
Margins
Gross margin is 100.00%, with operating and profit margins of -117.61% and -53.26%.
| Gross Margin | 100.00% |
| Operating Margin | -117.61% |
| Pretax Margin | -53.26% |
| Profit Margin | -53.26% |
| EBITDA Margin | n/a |
| EBIT Margin | -117.61% |
| FCF Margin | n/a |
Dividends & Yields
SCYNEXIS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.40% |
| Shareholder Yield | -25.40% |
| Earnings Yield | -18.64% |
| FCF Yield | -24.23% |
Analyst Forecast
The average price target for SCYNEXIS is $36.55, which is 578.11% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $36.55 |
| Price Target Difference | 578.11% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | -11.91% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 1, 2026. It was a reverse split with a ratio of 1:8.
| Last Split Date | Jun 1, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:8 |
Scores
SCYNEXIS has an Altman Z-Score of -4.56 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.56 |
| Piotroski F-Score | 2 |